• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Treatment strategies in essential arterial hypertension].

作者信息

Waeber B

机构信息

Division de physiopathologie, universitaire vaudois, Lausanne, Suisse.

出版信息

Rev Prat. 1999 Mar 1;49(5):520-5.

PMID:10358402
Abstract

Essential hypertension is a very heterogeneous disease. The availability of antihypertensive drugs lowering blood pressure by various mechanisms allows most often to tailor the treatment, i.e. to find for each patient a drug regimen that is both efficient and well tolerated. Frequently medications given as monotherapy are not effective enough so that the use of drug combinations is required. When combined, low doses of antihypertensive agents are generally sufficient, so that tolerability is optimally preserved. Unfortunately many patients do not have their blood pressure controlled during antihypertensive therapy. These patients therefore do not benefit maximally from the cardiovascular protection afforded by blood pressure lowering. It is also imperative to correct all cardiovascular risk factors in each hypertensive patient. Such a multifactorial approach is known to improve effectively the prevention of cardiovascular diseases.

摘要

相似文献

1
[Treatment strategies in essential arterial hypertension].
Rev Prat. 1999 Mar 1;49(5):520-5.
2
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
3
Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.高危患者的高血压管理:STRATHE和ADVANCE试验的经验与前景
J Hypertens Suppl. 2006 May;24(3):S19-27. doi: 10.1097/01.hjh.0000229465.09610.b6.
4
Low-dose combinations versus monotherapies in the treatment of hypertension.
J Hypertens Suppl. 1997 Mar;15(2):S17-20.
5
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
6
Combined therapy in the treatment of hypertension.联合疗法治疗高血压。
Fundam Clin Pharmacol. 2010 Feb;24(1):3-8. doi: 10.1111/j.1472-8206.2009.00749.x. Epub 2009 Aug 14.
7
Multiple drug therapy in the treatment of essential hypertension.多种药物联合治疗原发性高血压
Nurs Clin North Am. 1991 Jun;26(2):417-36.
8
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.
9
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?肾素-血管紧张素系统抑制对靶器官保护的作用:我们能否做得更好?
Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019.
10
Calcium channel blockers in hypertension. Is there still a controversy?高血压治疗中的钙通道阻滞剂。争议犹存?
Aging Clin Exp Res. 2005 Aug;17(4 Suppl):1-5.